Heartflow CMO sells 9,219 shares after option exercise

Heartflow, Inc. (HTFL) reported that Chief Medical Officer Campbell Rogers exercised stock options for 9,219 shares of common stock at an exercise price of $19.00 per share and sold the same 9,219 shares at $41.23 per share on August 17, 2026.

Rhea-AI Filing Summary

Heartflow, Inc. (HTFL) reported that Chief Medical Officer Campbell Rogers exercised stock options for 9,219 shares of common stock at an exercise price of $19.00 per share and sold the same 9,219 shares at $41.23 per share on August 17, 2026. The option position had 82,972 options remaining after the exercise and continues to vest monthly until August 7, 2029, with an expiration date of August 7, 2035. These transactions were effected under a Rule 10b5-1 Trading Plan adopted on December 12, 2025. Rogers also reports indirect holdings of common stock through various trusts, including 22,615; 46,159; 26,012; and 50,754 shares, respectively.

Insider Trade Summary 10b5-1

Exercise and Sale: 9,219 shares ($205K approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Rogers Campbell

Role Chief Medical Officer

Sold 9,219 shs ($380K)

Approx. gross sale proceeds $380K

Approx. exercise cost $175K

Approx. pre-tax spread $205K

Type	Security	Shares	Price	Value
Exercise	Stock Options F1, F2	9,219	$0.00	$0.00
Exercise	Common Stock F1	9,219	$19.00	$175K
Sale	Common Stock F1	9,219	$41.23	$380K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Options — 82,972 contracts (Direct); Common Stock — 86,459 shares (Direct); Common Stock — 22,615 shares (Indirect, By Campbell Rogers 2019 Irrevocable Trust); Common Stock — 46,159 shares (Indirect, By CR Asset Protection Trust of 2023); Common Stock — 26,012 shares (Indirect, By Spouse's Trust); Common Stock — 50,754 shares (Indirect, By The Campbell Rogers Revocable Trust)

Footnotes (2)

1. F1. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
2. F2. The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.

Key Figures

Options Exercised: 9,219 shares Exercise Price: $19.00 per share Sale Price: $41.23 per share +5 more

8 metrics

Options Exercised 9,219 shares Stock options exercised by Campbell Rogers on August 17, 2026

Exercise Price $19.00 per share Exercise price of stock options converted into common stock

Sale Price $41.23 per share Price for sale of 9,219 HTFL common shares on August 17, 2026

Options Remaining 82,972 shares Total stock options held by Campbell Rogers following the exercise

Indirect Holding - 2019 Irrevocable Trust 22,615 shares Common stock held indirectly by Campbell Rogers 2019 Irrevocable Trust

Indirect Holding - 2023 Asset Protection Trust 46,159 shares Common stock held indirectly by CR Asset Protection Trust of 2023

Indirect Holding - Spouse's Trust 26,012 shares Common stock held indirectly by Spouse's Trust

Indirect Holding - Revocable Trust 50,754 shares Common stock held indirectly by The Campbell Rogers Revocable Trust

Key Terms

Rule 10b5-1 Trading Plan, vests and becomes exercisable, Irrevocable Trust, Asset Protection Trust, +1 more

5 terms

Rule 10b5-1 Trading Plan regulatory

"were effected pursuant to a Rule 10b5-1 Trading Plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

vests and becomes exercisable financial

"The option vests and becomes exercisable in monthly installments"

Irrevocable Trust financial

"By Campbell Rogers 2019 Irrevocable Trust"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

Asset Protection Trust financial

"By CR Asset Protection Trust of 2023"

exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HTFL Chief Medical Officer Campbell Rogers report on August 17, 2026?

Campbell Rogers reported exercising 9,219 stock options at $19.00 and selling 9,219 common shares at $41.23 on August 17, 2026. The transactions relate to Heartflow, Inc. (HTFL) equity awards and resulted in reduced net common share exposure from this grant.

At what prices did Campbell Rogers exercise and sell HTFL shares in this Form 4?

He exercised options at an exercise price of $19.00 per share and sold the acquired common shares at $41.23 per share. Both the exercise and sale involved 9,219 shares of Heartflow, Inc. (HTFL) common stock on the same date.

How many Heartflow (HTFL) stock options does Campbell Rogers retain after this Form 4 transaction?

After the reported option exercise, Campbell Rogers held 82,972 stock options on August 17, 2026. The option continues to vest in monthly installments until August 7, 2029, and carries an expiration date of August 7, 2035, subject to continued service.

Was Campbell Rogers’ sale of HTFL stock under a Rule 10b5-1 trading plan?

Yes. The option exercise and share sale were carried out under a Rule 10b5-1 Trading Plan adopted on December 12, 2025. Such pre-arranged plans allow insiders to schedule trades in advance under defined parameters.

What indirect holdings in Heartflow (HTFL) does Campbell Rogers report through trusts?

Rogers reports indirect ownership of HTFL common stock via several trusts: 22,615 shares by the Campbell Rogers 2019 Irrevocable Trust, 46,159 shares by the CR Asset Protection Trust of 2023, 26,012 shares by a Spouse's Trust, and 50,754 shares by The Campbell Rogers Revocable Trust.

How does the reported option grant for HTFL vest and when does it expire?

The option vests and becomes exercisable in monthly installments until August 7, 2029, conditioned on continued service. It carries an expiration date of August 7, 2035, after which any unexercised portion would lapse under the award’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 09:05 PM EDT Accepted by SEC EDGAR 08/19/2026 - 09:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rogers Campbell

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/17/2026		M(1)		9,219	A	$19	95,678	D
Common Stock	08/17/2026		S(1)		9,219	D	$41.23	86,459	D
Common Stock								22,615	I	By Campbell Rogers 2019 Irrevocable Trust
Common Stock								46,159	I	By CR Asset Protection Trust of 2023
Common Stock								26,012	I	By Spouse's Trust
Common Stock								50,754	I	By The Campbell Rogers Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$19	08/17/2026		M(1)			9,219	(2)	08/07/2035	Common Stock	9,219	$0	82,972	D

Explanation of Responses:

1. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

2. The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.

	/s/ Nga Van, by power of attorney	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)